J. Austin-Breneman

Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade.

L. Chin, R. Davis, I. Wistuba, 2016, Cancer discovery.

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

E. Le Chatelier, N. Pons, N. Ajami, 2018, Science.

Therapeutic targeting and monitoring tumor immunity in melanoma

J. Wargo, Z. Cooper, J. Austin-Breneman, 2015 .

Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma

L. Chin, R. Sullivan, K. Flaherty, 2016, Oncoimmunology.

The MIT D-lab electricity-free PortaTherm™ incubator for remote testing with the QuantiFERON®-TB Gold In-Tube assay.

D. Moore, R. Yataco, M. Brady, 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma

Hannah C. Beird, Jeffrey E. Lee, L. Chin, 2017, npj Genomic Medicine.

Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance

P. A. Futreal, L. Chin, J. Wargo, 2017, Science Translational Medicine.

Raising the bar: optimizing combinations of targeted therapy and immunotherapy.

J. Wargo, A. Reuben, Z. Cooper, 2015, Annals of translational medicine.

Does It MEK a Difference? Understanding Immune Effects of Targeted Therapy

J. Wargo, A. Reuben, Z. Cooper, 2015, Clinical Cancer Research.

Working with Human Tissues for Translational Cancer Research.

J. Wargo, V. Gopalakrishnan, A. Reuben, 2015, Journal of visualized experiments : JoVE.

Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma

Hannah C. Beird, Jeffrey E. Lee, L. Chin, 2017, npj Genomic Medicine.

Does It MEK a Difference? Understanding Immune Effects of Targeted Therapy

J. Wargo, A. Reuben, Z. Cooper, 2015, Clinical Cancer Research.